2,3-DHB ineffective in treatment of iron overload.
1977
C M Peterson, and
R W Grady, and
R L Jones, and
A Cerami, and
J H Graziano, and
A L Markenson, and
U Lavi, and
V Canale, and
G F Gray, and
D R Miller
UI
MeSH Term
Description
Entries
D002986
Clinical Trials as Topic
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Clinical Trial as Topic
D004341
Drug Evaluation
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013789
Thalassemia
A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
Thalassemias
D062385
Hydroxybenzoates
Benzoate derivatives substituted by one or more hydroxy groups in any position on the benzene ring.
Hydroxybenzoic Acids,Acids, Hydroxybenzoic
Related Publications
C M Peterson, and
R W Grady, and
R L Jones, and
A Cerami, and
J H Graziano, and
A L Markenson, and
U Lavi, and
V Canale, and
G F Gray, and
D R Miller